Magnesium Glycinate | C4H8MgN2O4 | CID 84645 PubChem [Internet]
DOI: 10.1111/apha.13846
There is compelling evidence, including low plasma levels of GSH [12, 13], and effective antioxidant therapies (both with GSH [14] and its precursor, N-acetylcysteine [14, 15]), of REDOX imbalance contributing to the pathophysiology of several brain conditions such as obsessive-compulsive disorder, schizophrenia, bipolar disorder, autism, trichotillomania, and neurodegenerative disorders (see refs
Starting at a younger age may help prevent premature aging and reduce pigmentation issues and oxidative damage
Ideal for individuals with sleep disorders or insomnia
Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats